Trial Details

COMPLETED
Basic Information
Clinical ID c3868
Identifier NCT01411800
Trial Title An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions DRUG: 250 mg capsule|DRUG: 250 mg tablets
Participant Information
Sponsor Lexicon Pharmaceuticals
City Overland Park
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2011-08
Primary Completion Date 2011-10
Completion Date 2012-05